DiaMedica Therapeutics (DMAC) Shares Issued (2018 - 2026)

DiaMedica Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 26.8% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 26.8% increase from a year earlier, with the FY2025 full-year figure at $6.9 million, up 46.3% from the prior year.
• Shares Issued fell to $6.4 million in Q1 2026 per DMAC's latest filing, from $6.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $7.3 million in Q3 2025 and bottomed at $2.2 million in Q1 2022.
• The 5-year median for Shares Issued is $4.3 million (2024), against an average of $4.4 million.
• Across the five-year window, Shares Issued surged 84.65% in 2022 and gained 18.58% in 2025, its largest moves.
• Year by year, Shares Issued stood at $2.8 million in 2022, then jumped by 39.13% to $3.9 million in 2023, then rose by 21.22% to $4.7 million in 2024, then soared by 46.3% to $6.9 million in 2025, then retreated by 6.7% to $6.4 million in 2026.
• Per Business Quant, the three latest DMAC Shares Issued figures stand at $6.4 million (Q1 2026), $6.9 million (Q4 2025), and $7.3 million (Q3 2025).